Results
1 -
10 of
106Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer, Cancer Chemotherapy and Pharmacology Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia, Cancer Chemotherapy and Pharmacology Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors, Naunyn-Schmiedeberg's Archives of Pharmacology Fludarabine phosphate in lymphoma: an important new therapeutic agent, Advances in Lymphoma Research Evidence of Inhibition of DNA Methylation by Fludarabine, Purine and Pyrimidine Metabolism in Man X Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: Biology, clinical impact, and future directions, Leukemia: Advances in Research and Treatment Chemotherapy of Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia NONMEM Population Models of Cytosine Arabinoside and Fludarabine Phosphate in Pediatric Patients With Leukemia, Deoxynucleoside Analogs In Cancer Therapy Modulation of Ara-CToxification by Fludarabine and Hydroxyurea in Leukemic Blasts, Acute Leukemias VIII The Use of Fludarabine in Chronic Lymphocytic Leukemia and Malignant Lymphomas, Acute Leukemias V